Location · Houston, TX
Clinical trials in Houston, TX
838 recruiting studies have a site in the Houston area, and 205 of them accept healthy volunteers. The area includes Pasadena, Sugar Land, The Woodlands, Katy, Pearland, Baytown and nearby cities.
838 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- Recruiting
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Endotronix, Inc.
- Location
- Phoenix, AZ + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients
GE Healthcare
- Location
- Rochester, MN + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Pharming Technologies B.V.
- Location
- Orange, CA + 10 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair
Auxilium Biotechnologies
- Location
- San Diego, CA + 7 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
Cerium Pharmaceuticals, Inc.
- Location
- Los Angeles, CA + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in…
Apellis Pharmaceuticals, Inc.
- Location
- Gilbert, AZ + 77 other US sites
- Eligibility basics
- Ages 60+
- RecruitingPhase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Ansun Biopharma, Inc.
- Location
- Duarte, CA + 18 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Novartis Pharmaceuticals
- Location
- Huntsville, AL + 29 other US sites
- Eligibility basics
- Ages 50–80
- RecruitingPhase 1
Study of BHV-1400 in IgA Nephropathy
Biohaven Therapeutics Ltd.
- Location
- Farmington, CT + 13 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Bristol-Myers Squibb
- Location
- Bentonville, AR + 19 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1)
Amplifi Vascular, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
Neurocrine Biosciences
- Location
- Bryant, AR + 17 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Global Trial in APG2575 for Patients With CLL/SLL
Ascentage Pharma Group Inc.
- Location
- Tuscon, AZ + 10 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney…
Alexion Pharmaceuticals, Inc.
- Location
- Phoenix, AZ + 28 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Alexion Pharmaceuticals, Inc.
- Location
- Loma Linda, CA + 4 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
AbbVie
- Location
- Huntsville, AL + 46 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
Pfizer
- Location
- Little Rock, AR + 13 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
Oneness Biotech Co., Ltd.
- Location
- Fountain Valley, CA + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
AbbVie
- Location
- Dothan, AL + 32 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 1
R-2487 in Patients With Rheumatoid Arthritis
Rise Therapeutics LLC
- Location
- San Diego, CA + 5 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
Rivermark Medical
- Location
- Bakersfield, CA + 18 other US sites
- Eligibility basics
- Ages 45+ · Men only
- Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Abbott Medical Devices
- Location
- Phoenix, AZ + 56 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
Neurona Therapeutics
- Location
- Birmingham, AL + 34 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
Recursion Pharmaceuticals Inc.
- Location
- St Louis, MO + 6 other US sites
- Eligibility basics
- Ages 18+